Allspring Global Investments’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $145K | Sell |
17,394
-1,011
| -5% | -$8.45K | ﹤0.01% | 1569 |
|
2025
Q1 | $144K | Buy |
18,405
+6,453
| +54% | +$50.7K | ﹤0.01% | 1679 |
|
2024
Q4 | $178K | Buy |
11,952
+28
| +0.2% | +$417 | ﹤0.01% | 1685 |
|
2024
Q3 | $182K | Sell |
11,924
-884
| -7% | -$13.5K | ﹤0.01% | 1688 |
|
2024
Q2 | $195K | Sell |
12,808
-132
| -1% | -$2.01K | ﹤0.01% | 1711 |
|
2024
Q1 | $244K | Buy |
12,940
+1,090
| +9% | +$20.6K | ﹤0.01% | 1665 |
|
2023
Q4 | $226K | Buy |
11,850
+2,516
| +27% | +$48.1K | ﹤0.01% | 1663 |
|
2023
Q3 | $168K | Buy |
9,334
+230
| +3% | +$4.13K | ﹤0.01% | 1808 |
|
2023
Q2 | $185K | Sell |
9,104
-6,968
| -43% | -$142K | ﹤0.01% | 1833 |
|
2023
Q1 | $293K | Buy |
16,072
+3,703
| +30% | +$67.5K | ﹤0.01% | 1720 |
|
2022
Q4 | $256K | Sell |
12,369
-828
| -6% | -$17.1K | ﹤0.01% | 1763 |
|
2022
Q3 | $345K | Buy |
13,197
+3,315
| +34% | +$86.7K | ﹤0.01% | 1665 |
|
2022
Q2 | $250K | Sell |
9,882
-9,668
| -49% | -$245K | ﹤0.01% | 1753 |
|
2022
Q1 | $616K | Sell |
19,550
-700
| -3% | -$22.1K | ﹤0.01% | 2133 |
|
2021
Q4 | $819K | Buy |
+20,250
| New | +$819K | ﹤0.01% | 2055 |
|